QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is QuiaPEG Pharmaceuticals Holding AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. QuiaPEG Pharmaceuticals Holding AB's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

QuiaPEG Pharmaceuticals Holding AB ROCE % Historical Data

The historical data trend for QuiaPEG Pharmaceuticals Holding AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuiaPEG Pharmaceuticals Holding AB ROCE % Chart

QuiaPEG Pharmaceuticals Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-451.78

-806.40

-192.41

-91.13

-94.37

QuiaPEG Pharmaceuticals Holding AB Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-77.54	-51.12	-74.88	-	-

QuiaPEG Pharmaceuticals Holding AB ROCE % Calculation

QuiaPEG Pharmaceuticals Holding AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-15.51	/	( ( (23.442 - 5.823)	+	(41.959 - 26.708) )	/ 2 )
	=	-15.51	/	( (17.619	+	15.251)	/ 2 )
	=	-15.51	/	16.435
	=	-94.37 %

QuiaPEG Pharmaceuticals Holding AB's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	0	/	( ( (24.55 - 4.17)	+	(41.959 - 26.708) )	/ 2 )
	=	0	/	( ( 20.38	+	15.251 )	/ 2 )
	=	0	/	17.8155
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

QuiaPEG Pharmaceuticals Holding AB ROCE % Related Terms

Thank you for viewing the detailed overview of QuiaPEG Pharmaceuticals Holding AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

99B0:Germany

Address

Virdings Alle 32 B, Uppsala Business Park, Uppsala, SWE, 754 54

Website

http://www.quiapeg.com

QuiaPEG Pharmaceuticals Holding AB is a biotech company. It develops biopharmaceuticals based PEGylation technologies platform, which is applicable to proteins, peptides, and small molecules or oligonucleotides.

QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) Headlines

No Headlines